OverviewSuggest Edit

MYnd Analytics is a predictive analytics company that has developed a decision support tool to help physicians reduce trial and error treatment in mental health and provide more personalized care to patients. The Company provides objective clinical decision support to mental healthcare providers for the personalized treatment of behavioral disorders, including depression, anxiety, bipolar disorder, post-traumatic stress disorder (“PTSD”) and other non-psychotic disorders. The Company uses its proprietary neurometric platform, PEER Online, to generate Psychiatric EEG Evaluation Registry (“PEER”) Reports to predict the likelihood of response by an individual to a range of medications prescribed for the treatment of behavioral disorders.

TypePublic
Founded2000
HQMission Viejo, US
Websitemyndanalytics.com
Employee Ratings0

Latest Updates

Employees (est.) (Dec 2016)6
Revenue (FY, 2018)$1.3 M
Share Price (May 2019)$1 (-12%)

Key People/Management at MYnd Analytics

George C. Carpenter

George C. Carpenter

President and Chief Executive Officer
Brian MacDonald

Brian MacDonald

Chief Technology Officer
Donald DAmbrosio

Donald DAmbrosio

Chief Financial Officer and Secretary
R. Stewart Navarre

R. Stewart Navarre

Vice President, Government Accounts
Show more

MYnd Analytics Office Locations

MYnd Analytics has an office in Mission Viejo
Mission Viejo, US (HQ)
26522 La Alameda #290
Show all (1)

MYnd Analytics Financials and Metrics

MYnd Analytics Revenue

MYnd Analytics's revenue was reported to be $1.32 m in FY, 2018
USD

Revenue (Q2, 2019)

460.1k

Gross profit (Q2, 2019)

163.8k

Gross profit margin (Q2, 2019), %

35.6%

Net income (Q2, 2019)

(2.7m)

EBIT (Q2, 2019)

(2.7m)

Market capitalization (22-May-2019)

9.7m

Closing stock price (22-May-2019)

1.0

Cash (31-Mar-2019)

1.2m
MYnd Analytics's current market capitalization is $9.7 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

1.3m

Cost of goods sold

827.4k

Gross profit

488.1k

Gross profit Margin, %

37%
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Revenue

122.0k459.9k391.7k387.1k460.1k

Cost of goods sold

84.9k298.3k244.2k225.1k296.3k

Gross profit

37.1k161.6k147.5k162.0k163.8k

Gross profit Margin, %

30%35%38%42%36%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

1.3m1.2m432.1k318.2k5.4m3.3m

Accounts Receivable

26.6k9.3k11.8k5.1k6.5k63.3k

Current Assets

1.4m1.3m548.2k1.2m5.7m3.5m

PP&E

120.7k110.8k
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Cash

663.0k783.8k63.9k445.7k141.8k823.8k440.2k430.8k1.0m1.8m409.3k2.7m2.4m2.6m1.5m1.2m

Accounts Receivable

18.4k7.1k5.8k9.0k11.9k3.8k6.8k3.2k3.2k7.2k6.0k81.1k218.6k137.4k120.0k154.4k

Current Assets

714.1k891.3k166.8k481.3k252.6k906.8k617.6k606.8k1.7m2.3m535.7k2.8m2.8m3.1m1.8m1.5m

PP&E

136.4k143.1k127.0k98.8k87.7k
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(10.9m)(2.7m)(3.4m)(5.9m)(7.1m)(10.3m)

Depreciation and Amortization

13.0k10.3k7.6k7.2k48.7k117.9k

Accounts Payable

(63.4k)(15.8k)(182.9k)301.5k(432.7k)

Cash From Operating Activities

(3.0m)(3.3m)(2.1m)(3.0m)(4.8m)(9.0m)
USDY, 2019

Financial Leverage

6.1 x
Show all financial metrics

MYnd Analytics Online and Social Media Presence

Embed Graph

MYnd Analytics News and Updates

MYnd Analytics Provides Business and Merger Updates

Merger with Emmaus on Track to Close

MYnd Analytics Partners with Care Compass Network to Offer Telebehavioral Health Services

MISSION VIEJO, Calif., May 08, 2019 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (NASDAQ: MYND), a behavioral health company with tools and technologies aimed at improving the delivery of mental health services through the combination of telemedicine and data analytics, today announced that its wholly…

MYnd Analytics Interviewed on Bloomberg International on the RedChip Money Report

MISSION VIEJO, Calif., May 06, 2019 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (NASDAQ: MYND), a behavioral health company with tools and technologies aimed at improving the delivery of mental health services through the combination of telemedicine and data analytics, today announced an interview wi…

MYnd Analytics Interview to Air on Bloomberg International on the RedChip Money Report

MISSION VIEJO, Calif., April 17, 2019 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (NASDAQ: MYND), a behavioral health company with tools and technologies aimed at improving the delivery of mental health services through the combination of telemedicine and data analytics, today announced an interview …

MYnd Analytics CEO to Present at the ThinkEquity Conference in New York City

MISSION VIEJO, Calif., April 15, 2019 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (NASDAQ: MYND), a behavioral health company with tools and technologies aimed at improving the delivery of mental health services through the combination of telemedicine and data analytics, today announced that Patrick …

Lifshitz & Miller LLP Announces Investigation of AmpliPhi Biosciences Corporation, Churchill Capital Corporation, DaVita Inc., Flex Pharma, Inc., MYnd Analytics, Inc., SunCoke Energy Partners, L.P., Top Image Systems Ltd., and Uniti Financial Corporation

NEW YORK, April 5, 2019 /PRNewswire/ -- AmpliPhi Biosciences Corporation (APHB) Lifshitz & Miller announces investigation into possible breach of fiduciary duties in connection with the sale of APHB to C3J Therapeutics, Inc. If you are a APHB investor, and would like additional...
Show more

MYnd Analytics Blogs

Arcadian Telepsychiatry Signs Agreement with Memorial Hospital at Gulfport to Provide Telehealth Services

GULFPORT, Miss., May 20, 2019 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (NASDAQ: MYND), a behavioral health company with tools and technologies aimed at improving the delivery of mental health services through the combination of telemedicine and data analytics, today announced that Arcadian Teleps…

MYnd Analytics Awarded European Patent on Neuromodulation Platform; Predicts Patients Likely to Respond to TMS for Treating Depression

MISSION VIEJO, Calif., March 28, 2019 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (NASDAQ: MYND), a behavioral health company with tools and technologies aimed at improving the delivery of mental health services through the combination of telemedicine and data analytics, today announced it has recei…

MYnd Analytics Joins Magellan Healthcare Provider Network to Offer Telebehavioral Health Services

MISSION VIEJO, Calif., March 13, 2019 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (NASDAQ: MYND), a predictive analytics company aimed at improving the delivery of mental health through the combination of telemedicine and data analytics, today announced that its wholly owned subsidiary, Arcadian Tel…

MYnd Analytics and Arcadian Telepsychiatry Services Announce Partnership with IMPACT Solutions to Provide Tele-EAP Services

MISSION VIEJO, Calif., March 04, 2019 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (NASDAQ: MYND), a market leader in improving the delivery of mental health through the combination of telemedicine and data analytics/augmented intelligence, today announced a partnership with IMPACT Solutions, a leadi…

U.S. General Services Administration Awards Federal Supply Schedule to MYnd Analytics to Provide Healthcare IT Services to the Federal Government

MISSION VIEJO, Calif., Feb. 04, 2019 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (NASDAQ: MYND), a predictive analytics company aimed at improving the delivery of mental health through the combination of telemedicine and data analytics, today announced that the U.S. General Services Administration h…

UPDATE: MYnd Analytics and Emmaus Life Sciences Provide Update to Shareholders Addressing Questions Related to Merger and Spin-off Transaction

MISSION VIEJO, Calif. and TORRANCE, Calif., Jan. 10, 2019 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (Nasdaq: MYND), a predictive analytics company aimed at improving the delivery of mental health services through the combination of telemedicine and data analytics, and Emmaus Life Sciences, Inc. (“…
Show more

MYnd Analytics Frequently Asked Questions

  • When was MYnd Analytics founded?

    MYnd Analytics was founded in 2000.

  • Who are MYnd Analytics key executives?

    MYnd Analytics's key executives are George C. Carpenter, Brian MacDonald and Donald DAmbrosio.

  • How many employees does MYnd Analytics have?

    MYnd Analytics has 6 employees.

  • What is MYnd Analytics revenue?

    Latest MYnd Analytics annual revenue is $1.3 m.

  • What is MYnd Analytics revenue per employee?

    Latest MYnd Analytics revenue per employee is $219.3 k.

  • Who are MYnd Analytics competitors?

    Competitors of MYnd Analytics include Breakthrough Behavioral, Joyable and Lyra Health.

  • Where is MYnd Analytics headquarters?

    MYnd Analytics headquarters is located at 26522 La Alameda #290, Mission Viejo.

  • Where are MYnd Analytics offices?

    MYnd Analytics has an office in Mission Viejo.

  • How many offices does MYnd Analytics have?

    MYnd Analytics has 1 office.